Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha

Detalhes bibliográficos
Autor(a) principal: Silva, Andréa M. V. da
Data de Publicação: 2019
Outros Autores: Alvarado-Arnez, Lucia Elena, Azamor, Tamiris, Batista-Silva, Leonardo Ribeiro, Calvo, Thyago Leal, Silva, Jane da, Andrade, Ana Carolina Magalhães, Xavier, Janaina Reis, Matos, Denise C. S., Moraes, Milton Ozório
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/32844
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_4546eac0c73902e6a38ef77822d8a127
oai_identifier_str oai:www.arca.fiocruz.br:icict/32844
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Silva, Andréa M. V. daAlvarado-Arnez, Lucia ElenaAzamor, TamirisBatista-Silva, Leonardo RibeiroCalvo, Thyago LealSilva, Jane daAndrade, Ana Carolina MagalhãesXavier, Janaina ReisMatos, Denise C. S.Moraes, Milton Ozório2019-04-29T16:36:29Z2019-04-29T16:36:29Z2019SILVA, Andréa M. V. da et al. Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p.179.https://www.arca.fiocruz.br/handle/icict/3284410.35259/32844Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Coordinación Nacional de Investigación. Universidad Privada Franz Tamayo. Bolívia.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosHepatite C CrônicaPolimorfismoInterferon LambdaChronic C HepatitisPolymorphismLambda InterferonHepatite C CrônicaPolimorfismo GenéticoHost-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alphainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/32844/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALORT_26.pdfapplication/pdf63602https://www.arca.fiocruz.br/bitstream/icict/32844/2/ORT_26.pdf70ee5c65db8fef7d868d18c77b9e1ca5MD52TEXTORT_26.pdf.txtORT_26.pdf.txtExtracted texttext/plain3734https://www.arca.fiocruz.br/bitstream/icict/32844/3/ORT_26.pdf.txt7d7024633e3942ca5dff5b266f057cf7MD53icict/328442023-04-26 16:58:57.494oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:58:57Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
title Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
spellingShingle Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
Silva, Andréa M. V. da
Hepatite C Crônica
Polimorfismo
Interferon Lambda
Chronic C Hepatitis
Polymorphism
Lambda Interferon
Hepatite C Crônica
Polimorfismo Genético
title_short Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
title_full Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
title_fullStr Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
title_full_unstemmed Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
title_sort Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha
author Silva, Andréa M. V. da
author_facet Silva, Andréa M. V. da
Alvarado-Arnez, Lucia Elena
Azamor, Tamiris
Batista-Silva, Leonardo Ribeiro
Calvo, Thyago Leal
Silva, Jane da
Andrade, Ana Carolina Magalhães
Xavier, Janaina Reis
Matos, Denise C. S.
Moraes, Milton Ozório
author_role author
author2 Alvarado-Arnez, Lucia Elena
Azamor, Tamiris
Batista-Silva, Leonardo Ribeiro
Calvo, Thyago Leal
Silva, Jane da
Andrade, Ana Carolina Magalhães
Xavier, Janaina Reis
Matos, Denise C. S.
Moraes, Milton Ozório
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva, Andréa M. V. da
Alvarado-Arnez, Lucia Elena
Azamor, Tamiris
Batista-Silva, Leonardo Ribeiro
Calvo, Thyago Leal
Silva, Jane da
Andrade, Ana Carolina Magalhães
Xavier, Janaina Reis
Matos, Denise C. S.
Moraes, Milton Ozório
dc.subject.other.pt_BR.fl_str_mv Hepatite C Crônica
Polimorfismo
Interferon Lambda
topic Hepatite C Crônica
Polimorfismo
Interferon Lambda
Chronic C Hepatitis
Polymorphism
Lambda Interferon
Hepatite C Crônica
Polimorfismo Genético
dc.subject.en.pt_BR.fl_str_mv Chronic C Hepatitis
Polymorphism
Lambda Interferon
dc.subject.decs.none.fl_str_mv Hepatite C Crônica
Polimorfismo Genético
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-04-29T16:36:29Z
dc.date.available.fl_str_mv 2019-04-29T16:36:29Z
dc.date.issued.fl_str_mv 2019
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA, Andréa M. V. da et al. Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p.179.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/32844
dc.identifier.doi.none.fl_str_mv 10.35259/32844
identifier_str_mv SILVA, Andréa M. V. da et al. Host-genetic combination based on IFNL3/IFNL4 polymorphism with other prognostic variables increases sustained response in antiviral therapy with pegylated interferon alpha. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 4., 2019; SEMINÁRIO ANUAL CIENTÍFICO E TECNOLÓGICO DE BIO-MANGUINHOS, 7., 2019, Rio de Janeiro. Anais... Rio de Janeiro: Bio-Manguinhos, 2019. p.179.
10.35259/32844
url https://www.arca.fiocruz.br/handle/icict/32844
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/32844/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/32844/2/ORT_26.pdf
https://www.arca.fiocruz.br/bitstream/icict/32844/3/ORT_26.pdf.txt
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
70ee5c65db8fef7d868d18c77b9e1ca5
7d7024633e3942ca5dff5b266f057cf7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009267125387264

Registros relacionados